biosig_rgb.png
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
19 janv. 2023 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 19, 2023 (GLOBE NEWSWIRE) -- To date, the Company's FDA 510(k)-cleared PURE EP™ System has been used in approximately 3,000 patient cases across the United States The...
biosig_rgb.png
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology
10 janv. 2023 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Leading Midwest healthcare system reports significant cost savings and noise reduction following evaluation of the PURE EP™ System Medical center...
TIP_link_300x300.jpg
Mobile ECG Devices Market Revenue to Cross $2.36Bn, Globally, by 2028 | Growing at 5.0% CAGR Say, The Insight Partners
10 janv. 2023 07h28 HE | The Insight Partners
New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Mobile ECG Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality,...
Growth Plus Reports Logo.jpg
Electrophysiology Devices Market Report (2022 to 2030) - Siemens Healthcare AG, Abbott Laboratories, General Electric Healthcare Company, Medtronic Plc. And Boston Scientific Corp.
21 déc. 2022 05h34 HE | Growth Plus Reports
Pune, Dec. 21, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global electrophysiology devices market is expected to clock at US$ 14.15 billion by 2030...
biosig_rgb.png
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
14 déc. 2022 16h30 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- - BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
14 déc. 2022 08h00 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
06 déc. 2022 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...
Optimizer® Smart Mini System
Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy
16 nov. 2022 16h14 HE | Impulse Dynamics
MARLTON, N.J., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, announced the 100th implant in...
Future Market Insights.png
Rising Incidences of Ocular disorders to Make the Visual Electrophysiology Market Reach US$ 475.3 Mn at a CAGR of 7.2% During the Forecast Period of 2022-32 | Future Market Insights, Inc. NEWARK, Del, Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEWARK, Del: The global visual electrophysiology market is valued at US$ 220.3 Mn as of now and expected to reach US$ 475.3 Mn by the year 2032 at a...
Bio-Sig-Logo-horiz.jpg
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
24 oct. 2022 11h03 HE | BioSig Technologies, Inc.
Westport, CT, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Medical Center of Excellence to leverage the Company’s PURE EP™ System to further its research and educational objectives as a leader in cardiac...